[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiopharmIQ BiopharmIQ by Amp

Several biotech companies have recently made significant announcements, including Incyte's FDA clearance for Opzelura for kids with atopic dermatitis and Genmab's acquisition of Merus for $X billion. Additionally, companies such as UTHR, CYTK, and IONS have reported positive results from clinical trials and studies. Biotech stocks are also experiencing significant movements, with some companies seeing substantial gains or losses.

Engagements: XXXXXX #

X Week XXXXXXX +22%
X Month XXXXXXX -XX%
X Months XXXXXXXXX -XXXX%
X Year XXXXXXXXX -XX%

Mentions: XX #

X Week XX -XX%
X Month XXX -XX%
X Months XXX -XX%
X Year XXXXX +7.50%

Followers: XXXXXX #

X Week XXXXXX +0.60%
X Month XXXXXX +2.20%
X Months XXXXXX +15%
X Year XXXXXX +24%

CreatorRank: XXXXXXX #

Social Influence #

Social category influence stocks finance cryptocurrencies currencies technology brands

Social topic influence $cdtx #4, $evax #1, $idya #1, $telo #3, $anro #2, $atai #5, $celc #1, $inbx #1, $kytx #1, $vor #1

Top accounts mentioned or mentioned by @pharmdca @bowtiedbiotech @yaireinhorn @biotech2k1 @biostocks @learnbiotech @andreagtc @geneinvesting @semodough @tomsilver39 @parasbiotech @persimmonti @duedoctor @jfais20 @quantumup1 @profoak @hothomaswphelps @amaymd @sportsbios @ohadhammer

Top Social Posts #

Top posts by engagements in the last XX hours

"📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for"
X Link @BiopharmIQ 2025-10-09T15:50Z 27.3K followers, 9662 engagements

"📌 Biotech Stock News 10/13 @ Midday $CGEN XX% COM701 Pooled Analysis $RCUS X% Median OS Data in Ph2 Study $ANAB X% Late-Breaking Presentation at ACR $BCAX X% Ficerafusp Alfa Granted Breakthrough Designation $MNKD X% FDA Review for Inhaled Insulin in Youth $ADGM X% Preliminary Acute Results from FULCRUM-VT $ONC X% Sonrotoclax Breakthrough Therapy Designation $CGEM X% Present Zipalertinib Data at ESMO $HCM X% FRUSICA-2 Registration Trial Data at ESMO $NTRA X% IMvigor011 Oral Presentation at ESMO $APGE X% Closed $345M Public Offering $MRNA X% Cancer Antigen Therapy Data at ESMO $EVAX X% EVX-01"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.3K followers, 8939 engagements

"🧬 Biotech Weekly News 9/2/25 - 9/5/25 Major Movers 📈 $CYTK XX% Presented New Aficamten Data $IONS XX% Olezarsen Landmark Trials Results $UTHR XX% TETON-2 Study Met Endpoint $AQST XX% FDA Will Not Require AdCom $OLMA XX% New Trial for Breast Cancer 📉 $WVE -XX% RestorAATion-2 Trial Update $THAR -XX% Presentations on TH104 $PMN -XX% DSMB Approval for Ph1b Trial $AGIO -XX% Update on PDUFA Goal Date $MBX -XX% Doses First Patient in Ph1 ****** X asset. Multiple shots on goal 💊 $CYTK aficamten looks like the rare true pipeline-in-a-pill A franchise play unfolding fast. Dont miss @BowTiedBiotechs"
X Link @BiopharmIQ 2025-09-05T22:57Z 27.3K followers, 13.7K engagements

"🧬 Biotech Stock News 09/24 Brought to you by Barb On the rise 📈 $QURE198% $CDTX17% $AKTX13% Under pressure 📉 $BIIB -X% $HRMY -XX% $ACAD-11% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-09-24T17:40Z 27.3K followers, 4067 engagements

"📢M&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B 🚨 💰 $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis 📈 XX% premium to Akeros pre-deal price 🧬 Adds Phase X FGF21 analog EFX to Novos metabolic portfolio 🗓 Deal closes by YE 2025 pending approvals 🤔 Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"
X Link @BiopharmIQ 2025-10-09T15:06Z 27.3K followers, 15.8K engagements

"📌 Biotech Stock News 8/11 @ Open 🔔 $IMAB XX% Enrollment Completed in Ph1b Study $TLSA XX% Ph2 IND Approval $AMPH XX% Approval for Iron Sucrose Injection $ARVN X% NDA for Vepdegestrant Accepted $KMDA X% FDA Approval of Plasma Collection Center $INO X% INO-3107 Long-Term Surgery Reduction $NVS X% Ianalumab Ph3 Trials Met Endpoint $OCGN X% $20M Direct Offering Announced $NRXP X% Fast Track Designation for NRX-100 $BIIB X% First Patient Dosed in Ph3 Study $LGVN -X% $17.5M Public Offering $PTN -X% 1-for-50 Reverse Stock Split $VERU -X% Modified Release Oral Enobosarm for Clinical Study $IOBT"
X Link @BiopharmIQ 2025-08-11T15:36Z 27.3K followers, 7215 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $AVXL Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.3K followers, XXX engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $INBX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $OSTX Phase 2b $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $RZLT Phase X $NKTR Phase 2b $PVLA Phase X $PRAX Phase X $ASMB Phase X $RCUS Phase X $ZNTL Phase X $WVE Phase X $VALN Phase X $ROIV Phase X $RYTM Phase X $RXRX Phase X $RAPT Phase X $PRTA Phase X $PCSA Phase X $PRAX Phase 2/3 $MRUS Phase 2"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 27.3K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase X $ZNTL Phase X $IOVA Phase X $IOVA Phase X $BBIO Phase X $GNLX Phase X $COYA Phase X $RXRX Phase X $PRTA Phase X $VALN Phase X $CGON Phase X $GNLX Phase X $EXEL Phase X $COGT Phase X $PCSA Phase X $IMVT Phase X $BMEA Phase X $EXEL Phase X $JAZZ Phase X $HOOK Phase X $ANRO Phase 2b $RYTM Phase X $AMGN Phase X $INCY"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 1055 engagements

"🧬 Biotech Stock News 09/23 Brought to you by Barb On the rise 📈 $ATAI XX% $GRAL X% $PROF X% Under pressure 📉 $SRRK -X% $VERU -X% $MBX -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-09-23T17:37Z 27.3K followers, 3821 engagements

"$RCKT XX% 📈 FDA Acceptance of BLA Resubmission KRESLADI a lentiviral vector (LV)-based gene tx for severe LAD-I PDUFA target action date March XX 2026 🎯 Access our free PDUFA report for more info: 👇 FDA CRLs/Approvals Prior Adcoms"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.3K followers, 1130 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $INBX Phase X $ATAI Phase 2b $LQDA Phase X $PROK Phase X $KZR Phase 2a $ALXO Phase X $ELDN Phase X $IFRX Phase 2a $IFRX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase X $ANAB Phase 2"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 54.6K engagements

"📌 Biotech Stock News 10/08 @ Open $EVAX XX% Expands AI-Immunology Platform $ATXS X% Navenibart Ph3 Trial Initiation $SPRY X% Favorable Patent Decision on neffy $LSTA X% Global ADC License Agreement $AARD X% FDA Alignment on Protocol Amendment $TRVI X% Oral Presentation at CHEST 2025 $AQST X% Broadens Patent Estate for Anaphylm $HOWL X% Fast Track Designation for WTX-124 $OSTX -X% Participation in Fall 2025 Conferences $IVA -X% Presenting Multiple Abstracts at AASLD $ZBIO -X% License Agreement for Autoimmune Candidates $VRCA -X% New Data on VP-315 for BCC $RIGL -X% First Patient Enrolled in"
X Link @BiopharmIQ 2025-10-08T15:45Z 27.3K followers, 7647 engagements

"📌 Biotech Stock News 10/3 @ Open $ANRO XX% ALTO-101 FDA Fast Track Designation $OVID XX% OV329 Data & $175M Private Placement $ALXO X% ASPEN-06 Ph2 Trial Update $CDTX X% BARDA Award for CD388 Development $EVAX X% EVX-01 New biomarker data @ SITC'25 $CADL X% Presentation @ SITC Meeting $ENTA X% Closing of Upsized Public Offering $BCAB X% Mecbotamab Vedotin Data @ SITC'25 $HOWL X% Posters @ SITC'25 $XLO X% Presentation @ SITC Meeting $JAZZ X% FDA Approves Zepzelca+Atezolizumab $SRPT X% New Data @ WMSC'25 $CHRS X% Poster Presentation @ SITC'25 $PALI X% Closing of $138M Offering $RHHBY X% FDA"
X Link @BiopharmIQ 2025-10-03T15:47Z 27.3K followers, 9673 engagements

"$OVID up XX% 📈 OV329 shows strong Ph1 results. Favorable safety no eye issues. Now advancing to Ph2a. Initiate in Q2 2026 and completion in mid-2027 Don't miss out on future Big Movers Access our FREE Big Mover Report 👇"
X Link @BiopharmIQ 2025-10-03T15:47Z 27.3K followers, 1370 engagements

"📌 Biotech Stock News 10/01 @ Open $PALI XX% Pricing of $120M Public Offering $ACOG XX% Pricing of $35M Public Offering $CPRX XX% $200M Share Repurchase Program $ARVN X% Present ARV-102 Data at MDS '25 $PHAR X% sNDA Acceptance & Priority Review for Leniolisib $AZN X% BLA Accepted for Enhertu $ILMN X% Secures $23.4M for Diagnostic Platform $TMO X% Prices Offering of Senior Notes $KURA X% Clinical Trial for AML Treatment $ADGM X% Completion of Enrollment for Trial $BMY X% Anti-Tau Antibody Granted Fast Track $ABBV X% $70M Manuf Expansion $CRSP X% Present Preclin Data on AATD at ESGCT $CCCC 2%"
X Link @BiopharmIQ 2025-10-01T16:29Z 27.3K followers, 7740 engagements

"📌 Biotech Stock News 10/10 @ Open $CDTX X% Present @ 10th ESWI Influenza Conf. $AZN X% Expand VA Manuf. Facility $OSTX X% OST-HER2 Ph2b OS Data $JNJ X% MDD Portfolio @ 2025 ECNP Congress $CRSP X% New Preclinical CTX460 Data $BIIB -X% New Zorevunersen Data @ 54th CNS Mtg. $BMY -X% To Acquire Orbital Therapeutics $ASMB -X% ABI-5366 Interim Ph1b Data @ IUSTI-EU $VIR -X% First Participant Dosed for VIR-5500 Trial $QNCX -X% Present Data @ 54th CNS Mtg. $CABA -X% Rese-cel Data @ ESGCT'25 $ANVS -XX% $6M Direct Offering See the image and comments for more details"
X Link @BiopharmIQ 2025-10-10T15:53Z 27.3K followers, 7704 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (2/3). $IMVT Phase X $HOOK Phase X $GNLX Phase X $GNLX Phase X $GLPG Phase X $EXEL Phase X $EXEL Phase X $EWTX Phase X $COYA Phase X $COGT Phase X $COGT Phase X $CGON Phase X $RNAC Phase X $BBIO Phase X $BMEA Phase X $BINV Phase 2a $BHVN Phase X $BHVN Phase X $ARGX Phase X $AMGN Phase X $ANRO Phase X $ANRO Phase 2b $ALKS Phase X $ELDN Phase X $ACLX Phase X $BIVI Phase 2b $KPTI Phase X $CRVS Phase X $ZVSA Phase 2a $ZBIO Phase X $VTGN Phase X $VTYX Phase X $VTYX Phase X $TERN Phase X $TARA Phase X $PHVS Phase X $MLTX Phase X $MBRX"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements

"🧬 Biotech Stock News 10/9 Brought to you by Barb On the rise 📈 $TELO XX% $AKRO XX% $NGNE XX% Under pressure 📉 $EDIT -X% $LPTX -X% $ACXP -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-09T18:22Z 27.3K followers, 3654 engagements

"Biotech Stock Catalyst Watchlist 🎯 Ph2 & Ph3 readouts in Q3 2025. $UTHR Phase X $ARCT Phase X $MLTX Phase X $QURE Phase 2/3 $ENTA Phase X $KALA Phase 2b $LTRN Phase X $LRMR Phase X $ENTX Phase X $MTSR Phase 2b $ATAI Phase 2b $GRI Phase 2a $HRMY Phase X $CLNN Phase X $NKTR Phase X $FBIO Phase X $LGVN Phase 2a $SKYE Phase 2a $PRAX Phase X Check out the image for more details"
X Link @BiopharmIQ 2025-09-21T19:05Z 27.3K followers, 52.4K engagements

"October Biotech PDUFA Pulse: 📡 Whats on the FDA Radar $JAZZ - Zepzelca + Tecentriq - Approved $ARQT - ZORYVE (roflumilast) Cream XXXX% $AMGN - Tezspire $GKOS - Epioxa (Epi-on) $GSK - Blenrep combinations (BVd & BPd) $SNDX - Revuforj (revumenib) $MRK - WINREVAIR (sotatercept-csrk) $RHHBY - Gazyva/Gazyvaro $REGN - Libtayo (cemiplimab) Check out this months PDUFA calendar"
X Link @BiopharmIQ 2025-10-03T16:10Z 27.3K followers, 16.7K engagements

"🧬 Biotech Weekly News - Largest single-day stock moves during the week ending 10/10/25 📈 $SPRB 1378% Breakthrough Therapy Designation $LPTX XX% $58.88M Private Placement $LXEO XX% FDA Discussions Progress & Data $TELO XX% New Findings in Prostate CA Model $ANIX XX% Completion Final Patient Visit 📉 $SKYE -XX% Topline Ph2a Data Reported $HUMA -XX% Pricing of $XX Million Offering $BMEA -XX% 52-Wk Results in Diabetes Study $ANVS -XX% $6M Direct Offering $CABA -XX% Rese-cel Data @ ESGCT'25"
X Link @BiopharmIQ 2025-10-10T22:41Z 27.3K followers, 13.9K engagements

"🧬 Biotech Weekly News 9/29/25 - 10/03/25 Major Movers 📈 $ENTA XX% Ph2b Study Results in RSV $ANRO XX% ALTO-101 FDA FTD Granted $TSHA XX% TSHA-102 FDA BTD Granted $ANAB XX% Separates Biopharma Operations $VOR XX% Late-Breaking Poster Presentation at ACR 📉 $MLTX -XX% 16-wk Results of VELA program $KALA -XX% Ph2b CHASE Topline Results $APLT -XX% Update Following Meeting w/ FDA $LRMR -XX% Long-Term Data from OLE Study $FBIO -XX% Update on NDA for CUTX-101 ***** $ENTA Fresh insights from @EnantaPharmas leadership on RSV data for Zelicapavir What it means now and whats next for the program."
X Link @BiopharmIQ 2025-10-03T22:32Z 27.3K followers, 28.8K engagements

"🧬 Biotech Stock News 10/10 Brought to you by Barb On the rise 📈 $CDTX X% Under pressure 📉 $QNCX -X% $CABA -X% $ANVS -XX% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-10T17:28Z 27.3K followers, 3043 engagements

"$TEVA -X% 📉 FDA Approves Expanded Indication for Uzedy once-monthly extended-release injectable suspension for Bipolar I disorder (BD-I) in adults Access our free PDUFA report for more info: 👇 FDA CRLs/Approvals Prior Adcoms More"
X Link @BiopharmIQ 2025-10-13T16:58Z 27.3K followers, 1473 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IDYA Darovasertib + crizotinib $JAZZ Zanidatamab $INBX Ozekibart (INBRX-109) Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2097 engagements

"📢 M&A News: BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 💵 Cash-and-stock deal valued at about $700m 📈 $13/sh (53% premium over ATXS last close) 💉 Adds navenibart long-acting injectable for HAE currently in Ph3 🤝 To close in Q1 2026 See image for more info 👇"
X Link @BiopharmIQ 2025-10-14T14:49Z 27.3K followers, 4967 engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $ADVM 3/34 $VTYX 3/34 $BDTX 2/34 Access our FREE hedge fund screener & search your fav tickers"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 2310 engagements

"🧬 Biotech Stock News 09/09 Brought to you by Barb X on the rise 📈 $TRML XX% $TELO XX% $XLO XX% X under pressure 📉 $TXG -X% $CTXR -X% $RAPP -XX% Catch the full breakdown in the latest video 🎥"
X Link @BiopharmIQ 2025-09-09T17:25Z 27.3K followers, 3509 engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: Novos $5.2B acquisition reshapes the GLP-1 rivalry rare-disease micro-caps soar AI and gene-editing deals accelerate and IBD drugs dominate headlines. @DueDoctor Rare disease biotechs: small stakes big moves: $SPRB +648% @A_May_MD THIS IS 🚨NOT🚨 A PITCH but the $PALI story is a fascinating one. @Biotech2k1 $SPRB: MPS3 $250750M potential BTD filing Q1 XX 5x upside if mgmt delivers. @BiopharmIQ Ph2 & Ph3 readouts in Q4 2025 @davidycli Only two types of founders getting funded right now in biotech @JKeynesAlpha $RXRX 🔥🔥🔥Recursion seems"
X Link @BiopharmIQ 2025-10-11T20:44Z 27.3K followers, 22.7K engagements

"📌 Biotech Stock News 07/30 🧬 📽 $VRDN XX% Collaboration & License Agreement w/ Kissei Pharma $IMNN X% First Patient Dosed in Ph3 Study $CELC X% Pricing of Public Offering $MIRA X% Topical Ketamir-2 Preclin Data $ACRS X% Results from ATI-2138 Ph2a Trial $CRBP X% CRB- XXX Ph1/2 Clinical Data at ESMO $TNYA X% Safety Reviews for Gene Trials $LRMR X% Pricing of Public Offering $ABBV X% Ph3 Topline Results from Alopecia Trial $BIIB X% New Data on Leqembi at AAIC $NAMS X% Data from BROADWAY Trial at AAIC $SNSE X% Clinical Data from Phase X Cohort at ESMO $MDGL X% Exclusive Global License for GLP-1"
X Link @BiopharmIQ 2025-07-30T21:29Z 27.3K followers, 3529 engagements

"1/ 🧵 Biotech Stock News 10/07 @ Open $LXEO XX% Progress in FDA Discussions & Data $TELO XX% New Findings in Prostate Cancer Model $KZIA XX% Collaboration & In-Licensing Agreement $ANIX XX% Completion of Final Patient Visit $DBVT XX% Sale of $XX million ADSs $DYN XX% One-Year Clinical Data for DM1 $CLLS X% Data on Non-Viral Gene Therapy $OGEN X% Strategic Partnership to Accelerate Pipeline $AVIR X% New Data on Hepatitis C Treatment $ABUS X% Four Abstracts Accepted for AASLD 2025 $MAIA X% Initiate Digital Asset Treasury Strategy $GALT X% Present at AASLD Liver Meeting 2025 $EPIX 2%"
X Link @BiopharmIQ 2025-10-07T15:57Z 27.3K followers, 8149 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $IFRX Phase 2a $IFRX Phase 2b $PTGX Phase 2b $EVAX Phase X $DCTH Phase X $CELC Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $ATAI Phase 2b $INBX Phase X $KZR Phase 2a $PROK Phase X $ELDN Phase X $PVLA Phase X $NKTR Phase 2b $RZLT Phase X $RCUS Phase X $ASMB Phase X $BDTX Phase X $RNA Phase X $CAPR Phase X $TARA Phase X $ZVSA Phase 2a $CGON Phase X $VTYX Phase X $DBVT Phase X $PHVS Phase X $VTGN Phase X $TERN Phase X $ALEC Phase X $ZBIO Phase X $IRON Phase X $INBX Phase 2/3 $MLTX Phase 2"
X Link @BiopharmIQ 2025-09-28T19:33Z 27.3K followers, 40.8K engagements

"Let's see how many of the XX biopharma-focused hedge funds hold these tickers. $IDYA 5/34 🔥 $JAZZ 4/34 $INBX 3/34 Access our FREE hedge fund screener & search your fav tickers"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, 2070 engagements

"Baker Bros. 🔔🐳 Q2 25* Holdings Released Holdings: XX Holdings in Top 20: XX% Qtr over Qtr Change**: XXXXX% Top Holdings 🚀: $ONC $INCY $ACAD $INSM $SMMT $MDGL $RYTM $RVMD $KYMR $ALKS $REPL $RARE $EWTX $ABCL $IMVT $GRAL $KNSA $BCYC $IMCR $CELC *Holdings as of 6/30/25 in SEC form 13F **Change in value of public company shares held See image for more details 👇"
X Link @BiopharmIQ 2025-08-14T22:20Z 27.3K followers, 15.6K engagements

"📢 M&A News: Genmab $GMAB to acquire Merus $MRUS for $8B 💰 $97/share all-cash (41% premium $8B EV) 🧬 Adds Phase X bispecific petosemtamab (BTD in head & neck cancer) Ph2 data showed strong ORR & PFS SOC; Ph3 readouts in 2026 Expected launch 2027 $1B sales by 2029 multi-billion potential longer term 🗓 Closing by Q1 2026 See photo for more info 👇"
X Link @BiopharmIQ 2025-09-29T14:40Z 27.3K followers, 10.4K engagements

"Exciting Q4 2023 BPIQ Big & Suspected Movers $EVAX $ACRS $CMPX And more See our free report of stock-moving catalysts to watch coming this quarter 🎉 👇"
X Link @BiopharmIQ 2025-10-08T15:45Z 27.3K followers, 2517 engagements

"$INCY ✅ FDA clears Incytes Opzelura for kids XXX with atopic dermatitis First topical JAK inhibitor approved in the U.S. for pediatric AD sNDA based on Phase X TRuE-AD3 trial - primary & secondary endpoints met - higher treatment success (IGA-TS) vs vehicle - more achieved EASI-75 at Wk X - no new safety concerns"
X Link @BiopharmIQ 2025-09-19T15:03Z 27.3K followers, 6366 engagements

"BioCryst $BCRX to Acquire Astria Therapeutics $ATXS 👇"
X Link @BiopharmIQ 2025-10-14T16:02Z 27.3K followers, 2065 engagements

"💰 $BMY to acquire Orbital Tx Adds OTX-201 an in vivo CAR-T Extends $BMY s cell tx into autoimmune diseases Check out our free biopharma M&A tracker: 👇 Provides info on past M&A activity"
X Link @BiopharmIQ 2025-10-10T15:54Z 27.3K followers, 1304 engagements

"📌 Biotech Stock News 09/17 @ Open $ROIV XX% Brepocitinib Ph3 Study Results $ORKA XX% ORKA-001 Interim Ph1 Results $ELTX X% ELI-002 Trial Update $ATXS X% Ph1a Trial Initial Results $NRIX X% Preclin Data on IRAK4 Degrader $AKTX X% New Patent Filing for ADC Platform $ARQT X% New ZORYVE Data Analyses $TNXP X% In-licensing of TNX-4800 $XFOR X% Restructuring of Business Operations $CLDX X% Barzolvolimab Data at EADV $PTGX X% PN-881 Data at EADV $CDTX X% CD388 Ph2b Data $CADL X% Ph3 Results of CAN-2409 $VTRS X% First Patient Recruited in Ph2/3 Study $REGN X% Ph2 Trial Results on GLP-1 Receptor"
X Link @BiopharmIQ 2025-09-17T17:00Z 27.3K followers, 9173 engagements

"🧬 Biotech Stock News 08/11 Brought to you by Barb X stocks on the rise 📈 $IMAB $TLSA $AMPH X under pressure 📉 $PTN $VERU $IOBT Catch the full breakdown in the latest video 🎥"
X Link @BiopharmIQ 2025-08-11T16:31Z 27.3K followers, 3616 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $AGIO Phase X $SLS Phase X $PCVX Phase X $ARTV Phase 2a $ALZN Phase X $IMMP Phase 2/3 $ALDX Phase X $TLPH Phase X $INAB Phase X $ALNY Phase X $LLY Phase X $BBIO Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $JAZZ Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $MRNA Phase X $DNLI Phase 2/3 $LSTA Phase 2b $INKT Phase X $STOK Phase X $ADAG Phase X $PBYI Phase X $ALDX Phase X $CNTA Phase 2a $RLMD Phase 2"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 1104 engagements

"🧬 Biotech Weekly News 9/8/25 - 9/12/25 Major Movers 📈 $RAPP XXX% Topline Data RAP-219 Ph2a Trial $TRML XX% Novartis Acquires Tourmaline Bio $MAZE XX% MZE782 Ph1 Trial Results $TVTX XX% FDA AdCom Meeting Update $ONCY XX% Highlights Data in CRC 📉 $SMMT -XX% Longer-Term Data in NSCLC $ACTU -XX% Pricing $15M Public Offering $IDYA -XX% Multiple Trial Readouts $NUVB -XX% New Data from NSCLC Studies $TIL -XX% Presentation 2510 Monotherapy Data ***** Impressive data drop from $RAPP 🔥 RAP-219 - strong seizure reduction in Focal Onset Epilepsy See @PersimmonTI post below. $XBI"
X Link @BiopharmIQ 2025-09-12T22:44Z 27.3K followers, 11.2K engagements

"🧬 Biotech Stock News 10/3 Brought to you by Barb On the rise 📈 $ANRO XX% $OVID XX% $ALXO X% Under pressure 📉 $AKTX -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-10-03T17:11Z 27.3K followers, 3142 engagements

"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $ADVM Ixoberogene soroparvovec (Ixo-vec) $VTYX VTX2735 $BDTX BDTX-1535 Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-05T20:24Z 27.3K followers, 2434 engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements

"📣 Biotech Stock News 09/09 @ Open $TRML XX% Novartis Acquires Tourmaline Bio $TELO XX% New Cancer Data on Prostate Cells $XLO XX% Initiation of Phase X Trial $MBRX X% Accelerates Recruitment in Phase X Trial $AGEN X% Reimbursed Compassionate Access for BOT/BAL $DNTH X% Proposed $XXX Million Public Offering $NKGN X% Completion of Acquisition and Control $NKTR X% REZOLVE-AD Phase 2b Results Presented $AVXL X% Cognitive Resilience Results in Alzheimer's Trial $IONS X% FDA Breakthrough Therapy designation for ION582 $EVFM X% Anticipates Merger Approval at Meeting $ACRS X% Late-Breaking Abstract"
X Link @BiopharmIQ 2025-09-09T15:46Z 27.3K followers, 9868 engagements